Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis

Clinical and Vaccine Immunology

Volumn 15, Issue 3, 2008, Pages 544-548

  Mizusawa, Masako ^a,e   Kawamura, Mizuoho ^b   Takamori, Mikio ^c   Kashiyama, Tetsuya ^c   Fujita, Akira ^c   Usuzawa, Motoki ^a   Saitoh, Hiroki ^a   Ashino, Yugo ^a   Yano, Ikuya ^d   Hattori, Toshio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kyowa Medex Co Ltd   (Japan)

^c TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^d Japan BCG Laboratory   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CARBOHYDRATE ANTIGEN; CD40 LIGAND; GLYCOLIPID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SIALYLATED CARBOHYDRATE ANTIGEN KL 6;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; LUNG CAVITATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; BIOSYNTHESIS; IMMUNOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; FEMALE; GLYCOLIPIDS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 42049101246     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00355-07     Document Type: Article

References (26)

1. Apostolou, I., Y. Takahama, C. Belmant, T. Kawano, M. Huerre, G. Marchal, J. Cui, M. Taniguchi, H. Nakauchi, J. J. Fournie, P. Kourilsky, and G. Gachelin. 1999. Murine natural killer T (NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA 96:5141-5146.
2. Ashino, J., Y. Ashino, H. Guio, H. Saitoh, M. Mizusawa, and T. Hattori. 2005. Low antibody response against tuberculous glycolipid (TBGL) in elderly gastrectomised tuberculosis patients. Int. J. Tuberc. Lung Dis. 9:1052-1053.
3. Aung, H., Z. Toossi, S. M. McKenna, P. Gogate, J. Sierra, E. Sada, and E. A. Rich. 2000. Expression of transforming growth factor-beta but not tumor necrosis factor-alpha, interferon-gamma and interleukin-4 in granulomatous lung lesions in tuberculosis. Tuber. Lung Dis. 80:61-67.
4. Chan, J., X. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59:1755-1761.
5. Enomoto, Y., M. Sugita, I. Matsunaga, T. Naka, A. Sato, T. Kawashima, K. Shimizu, H. Takahashi, Y. Norose, and I. Yano. 2005. Temperature- dependent biosynthesis of glucose monomycolate and its recognition by CD1-restricted T cells. Biochem. Biophys. Res. Commun. 337:452-456.
6. Falk, A., J. B. O'Connor, and P. C. Pratt. 1969. Classification of pulmonary tuberculosis, p. 68-76. In Diagnostic standards and classification of tuberculosis, 12th ed., vol. 6. National Tuberculosis and Respiratory Disease Association, New York, NY.
7. Hunter, S. W., H. Gaylord, and P. J. Brennan. 1986. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J. Biol. Chem. 261:12345-12351.
8. Inoue, Y., K. Nishimura, M. Shiode, H. Akutsu, H. Hamada, S. Fujioka, S. Fujino, A. Yokoyama, N. Kohno, and K. Hiwada. 1995. Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis. Tuber. Lung Dis. 76:230-233.
9. Juffermans, N. P., A. Verbon, S. J. H. van Deventer, W. A. Buurman, H. Van Deutekom, P. Speelman, and T. van der Poll. 1998. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J. Infect. Dis. 178:1839-1842.
10. Julián, E., L. Matas, A. Perez, J. Alcaide, M. A. Laneelle, and M. Luquin. 2002. Serodiagnosis of tuberculosis: comparison of immunoglobulin A (IgA) response to sulfolipid I with IgG and IgM responses to 2,3-diacyltrehalose 2,3,6-triacyltrehalose and cord factor antigens. J. Clin. Microbiol. 40:3782-3788.
11. Kawamura, M., N. Sueshige, K. Imayoshi, I. Yano, R. Maekura, and H. Kohno. 1997. Enzyme immunoassay to detect antituberculous glycolipid antigen (anti-TBGL antigen) antibodies in serum for diagnosis of tuberculosis. J. Clin. Lab. Anal. 11:140-145.
12. Kishimoto, T., O. Moriya, J. Nakamura, T. Matsushima, and R. Soejima. 1999. Evaluation of the usefulness of a serodiagnosis kit, the determiner TBGL antibody for tuberculosis: setting reference value. Kekkaku 74:701-706.
13. Kobayashi, J., and S. Kimura. 1995. KL-6: a serum marker for interstitial pneumonia. Chest 108:311-315.
14. Maekura, R., M. Nakagawa, Y. Nakamura, T. Hiraga, Y. Yamamura, M. Ito, E. Ueda, S. Yano, H. He, and S. Oka. 1993. Clinical evaluation of rapid serodiagnosis of pulmonary tuberculosis by ELISA with cord factor (trehalose-6,6′-dimycolate) as antigen purified from Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 148:997-1001.
15. Maekura, R., Y. Okuda, M. Nakagawa, T. Hiraga, S. Yokota, M. Ito, I. Yano, H. Kohno, M. Wada, C. Abe, T. Toyoda, T. Kishimoto, and T. Ogura. 2001. Clinical evaluation of anti-tuberculous glycolipid immunoglobulin G antibody assay for rapid serodiagnosis of pulmonary tuberculosis. J. Clin. Microbiol. 39:3603-3608.
16. Mazzei, G. J., M. D. Edgerton, C. Losberger, S. Lecoanet-Henchoz, P. Graber, A. Durandy, J. Gauchat, A. Bernard, B. Allet, and J. Bonnefoy. 1995. Recombinant soluble trimetric CD40 ligand is biologically active. J. Biol. Chem. 31:7025-7028.
17. Mempel, M., C. Ronet, F. Suarez, M. Gilleron, G. Puzo, L. V. Kaer, A. Lehuen, P. Kourilsky, and G. Gachelin. 2002. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. J. Immunol. 168:365-371.
18. Samten, B., E. K. Thomas, J. Gong, and P. F. Barnes. 2000. Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis. Infect. Immun. 68:3002-3006.
19. Snyder-Cappione, J. E., D. F. Nixon, C. P. Loo, J. M. Chapman, D. A. Meiklejohn, F. F. Melo, P. R. Costa, J. K. Sandberg, D. S. Rodrigues, and E. G. Kallas. 2007. Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. J. Infect. Dis. 195:1361-1364.
20. Vollmers, H. P., and S. Brändlein. 2006. Natural IgM antibodies: from parias to parvenas. Histol. Histopathol. 21:1355-1366.
21. Wiley, J. A., R. Geha, and A. G. Harmsen. 1997. Exogenous CD40 ligand induces a pulmonary inflammation response. J. Immunol. 158:2932-2938.
22. World Health Organization. 2007. Global tuberculosis control: surveillance, planning, financing: WHO report 2007. World Health Organization, Geneva, Switzerland.
23. Yarkoni, E., and H. J. Rapp. 1977. Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6′- dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets. Infect. Immun. 18:552-554.
24. 1-152 confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J. Immunol. 161:4244-4251.
25. Zan, H., A. Cerutti, P. Dramitinos, A. Schaffer, and P. Casali. 1998. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu→S alpha and sequential S mu→S gamma S gamm→S alpha DNA recombination. J. Immunol. 161:5217-5225.
26. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J. Clin. Investig. 91:2076-2083.